Zepp Health Corp (ZEPP) is an innovative technology company at the forefront of the global digital health market. It is committed to empowering individuals to manage their well-being through the use of cutting-edge technology and revolutionary health applications.
Originally known as Huami Corporation, Zepp Health Corp was founded in 2013 and went public in February 2018 on the New York Stock Exchange (NYSE). Its headquarters are currently based in Hefei, China, and Cupertino, California. As an innovative giant in the sector, Zepp Health Corp takes credit as one of the leading global producers of smart wearable technology.
Best known for developing biometric and activity data-driven solutions, Zepp Health Corp’s specializes in creating advanced health and fitness tracking devices that utilize AI technology. Notably, smartwatches and fitness bands are among the company’s main product offerings. Zepp and Amazfit are the two leading brands under Zepp Health Corp recognized for their unmatched quality and functionality.
Beyond just device manufacturing, Zepp Health Corp has made significant contributions to the field of health tech through its proprietary AI development. The company’s innovative AI chip, Huangshan-1, is designed to optimize the accuracy and efficiency of health monitoring metrics, which is a testament to the company's commitment to better health data management.
In addition to its focus on individual consumer health products, Zepp Health Corp also offers solutions fit for enterprise-level use. It has successfully established partnerships with leading tech companies worldwide like Timex Group, Xiaomi, and even certain healthcare authorities to provide software solutions and improve patient care.
What sets Zepp Health Corp apart is its strong commitment to R&D. The company has one of the most substantial patent portfolios in the industry with over 1,000 authorized patents, showcasing their continued focus on groundbreaking innovation.
Despite being a relatively young company, Zepp Health Corp has managed to carve out a significant niche for itself in the global digital health market. This is evident in its substantial growth in the past few years, with millions of products sold worldwide.
In summary, Zepp Health Corp, which combines leading edge technology with innovative health applications, is enthusiastic about improving lives and is a force to reckon with in the race towards smart health. Its unrelenting commitment to using data-driven solutions to transform health management systems is testament to that.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Zepp Health Corp's Chief Industrial Designer, Yu Pengtao, sold a total of 10,000 American depositary shares (ADS) in two separate transactions on September 23 and 24, 2026. The sales were conducted for personal tax arrangements, and following these transactions, Yu Pengtao directly holds 98,491 ADS. Each ADS represents 16 Class A ordinary shares, which were initially acquired through the vesting and settlement of restricted share units.
Despite its name, Amazfit smartwatches are not owned by Amazon; they are a brand of Zepp Health, a public company listed on the New York Stock Exchange. Zepp Health, founded in 2013 as Huami Corp and rebranded in 2021, uses "Zepp OS" and "Zepp" in its products, including the Amazfit line which launched in 2015. The company offers a range of smartwatches like the Bip, Active, Cheetah, T-Rex, and Balance series, along with smart rings and fitness trackers, targeting various consumer needs from basic functionality to rugged use.
Zepp Health Corporation announced it will report its second quarter 2026 unaudited financial results on Tuesday, September 1, 2026. A conference call for management will be held at 9:30 p.m. ET on the same day, with details provided for participants to access the call and a webcast. Zepp Health, a global leader in smart wearables and health technology, will also make a replay of the call available.
Zepp Health Corporation (NYSE: ZEPP) has announced that it will report its unaudited second-quarter 2026 financial results on Tuesday, September 1, 2026. The company will hold a conference call at 9:30 p.m. Eastern Time on the same day to discuss the results, with access details provided for both U.S. and international participants. A live and archived webcast will also be available on their investor relations website.
Wall Street Zen has upgraded Zepp Health (NYSE:ZEPP) from a "sell" to a "hold" rating, while Fundamental Research maintains a "buy" rating with a $53.01 price target. Zepp Health shares opened up 3% at $5.52, but remain near their 52-week low. Institutional investors own 52.61% of the stock, and CFO Cheng Deng recently sold shares to cover tax obligations.